![Ute Mercker](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ute Mercker
Directeur/Membre du Conseil chez OMEICOS Therapeutics GmbH
Postes actifs de Ute Mercker
Sociétés | Poste | Début | Fin |
---|---|---|---|
IBB Beteiligungsgesellschaft mbH
![]() IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Private Equity Investor | 01/11/1997 | - |
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | 01/03/2015 | - |
Historique de carrière de Ute Mercker
Anciens postes connus de Ute Mercker
Sociétés | Poste | Début | Fin |
---|---|---|---|
GenPat77 Pharmacogenetics AG
![]() GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - | 30/07/2008 |
Scienion AG
![]() Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Directeur/Membre du Conseil | 01/01/2001 | - |
Humedics GmbH
![]() Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | - | - |
Formation de Ute Mercker
Freie Universität Berlin | Masters Business Admin |
Statistiques
Internationale
Allemagne | 7 |
Opérationnelle
Director/Board Member | 4 |
Private Equity Investor | 1 |
Masters Business Admin | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 5 |
---|---|
IBB Beteiligungsgesellschaft mbH
![]() IBB Beteiligungsgesellschaft mbH Investment ManagersFinance IBB Beteiligungsgesellschaft mbH (IBB Ventures) is the wholly-owned venture capital subsidiary of Investitionsbank Berlin. The firm was founded in 1997 to foster the development of regional businesses in selected areas and to strengthen the local labor market. The firm is headquartered in Berlin, Germany. | Finance |
GenPat77 Pharmacogenetics AG
![]() GenPat77 Pharmacogenetics AG Miscellaneous Commercial ServicesCommercial Services GenPat77 Pharmacogenetics AG researches and develops immune modulatory therapeutics for immune mediated diseases. The company was founded in 1998 and is headquartered in Berlin, Germany. | Commercial Services |
Humedics GmbH
![]() Humedics GmbH Packaged SoftwareTechnology Services Humedics GmbH operates as a research-based medtech company. It focuses on rapid and precise lover function measurement using LiMax, a breath analysis technology. The company was founded by Martin Stockman, Erwin de Bujizer, and Karsten Heyne in 2009 and is headquartered in Berlin, Germany. | Technology Services |
Scienion AG
![]() Scienion AG BiotechnologyHealth Technology Scienion AG develops and provides DNA biochips and protein microarrays. It provides its customers in the pharmaceutical, biotech, diagnostic and reagent supply markets, as well as in academic research institutions with products, and services to facilitate confidence and efficiency in aspects of its applications. The company was founded by Holger Eickhoff in 2000 and is headquartered in Dortmund, Germany. | Health Technology |
OMEICOS Therapeutics GmbH
![]() OMEICOS Therapeutics GmbH BiotechnologyHealth Technology OMEICOS Therapeutics GmbH develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation. It operates as a biopharmaceutical company developing molecule therapeutics for the prevention and treatment of cardiovascular diseases including atrial fibrillation. The company was founded by Wolf-Hagen Schunck, John R. Falck, Dominik Müller, Robert Fischer and Karen Uhlmann in 2013 and is headquartered in Berlin, Germany. | Health Technology |
- Bourse
- Insiders
- Ute Mercker
- Expérience